Phase 2 Clinical Trial of Crizotinib for Children and Adults With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas

NCT04283669 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Neurofibromatosis 2
Progressive Vestibular Schwannoma (VS)

Interventions

DRUG: Crizotinib

Sponsor

University of Alabama at Birmingham

Collaborators

[object Object]
[object Object]